Psyence Biomedical PBM
NASDAQ PBM
$4.16 +0.05 (+1.09%)
At close: Oct 23, 2026 · 4:00 PM EDT

Psyence Biomedical (PBM) Other Accumulated Expenses (2022 - 2024)

Updated

Psyence Biomedical's Other Accumulated Expenses came in at $1.25 million for the quarter ended Sep 30, 2024, compared with $70,000 a year earlier.

Analysis

Psyence Biomedical (PBM) Other Accumulated Expenses (2022 - 2024) Analysis & Trends

As of Mar 31, 2024, Psyence Biomedical's Other Accumulated Expenses was $1.47 million.

  • The five-year range for quarterly Other Accumulated Expenses is $70,000 (the quarter ended Sep 30, 2023) to $1.47 million (the quarter ended Mar 31, 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Psyence Biomedical 2.26 Mn -20.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.25 Mn
Mar 31, 2024 1.47 Mn
Sep 30, 2023 70,000.00
Dec 31, 2022 100,000.00
API Access

Psyence Biomedical Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=PBM&period=max&api_key=YOUR_API_KEY